Back

Optimizing clinical outcomes in acute decompensated heart failure. The role of Landiolol.

22 May 2022 (10:00 - 10:20)
Organised by:
Congress Presentation Part of: When the heart begins to race acutely - overcoming existing therapy limits with Landiolol Cardiovascular Pharmacotherapy Open Access Heart Failure 2022

About the speaker

Photo
Doctor Marek Sramko

Institute for Clinical and Experimental Medicine (IKEM), Prague (Czechia)

2 More presentations in this session

Presentation thumbnail
Short acting beta-blockers in critical ill patients.
Associate Professor W. Speidl (Vienna, AT)
Slides Video
Presentation thumbnail
Questions & Answers.
Professor G. Dan (Bucharest, RO)
Video

Access the full session

Session thumbnail
When the heart begins to race acutely - overcoming existing therapy limits with Landiolol
Video

The Event

Event poster

Heart Failure 2022

22 May 2022 10:00 CET
You may be interested in
thumbnail
Congress Presentation
When the left heart fails because of acute arrhythmia: acute rate control in atrial fibrillation and using landiolol
25 August 2023
thumbnail
Congress Session
Acute heart failure: in-hospital journey
22 May 2022
thumbnail
Congress Presentation
Medical treatment of atrial fibrillation
17 May 2025
thumbnail
Congress Presentation
Rate control first for most atrial fibrillation patients: beta-blocker and/or digitalis?
29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources